United States Últimas notícias

UK Artificial Intelligence Minister Kanishka Narayan discusses government policy around the adoption of AI and safety concerns about the technology. Britain needs a "sovereign level of compute," Narayan tells Bloomberg's Caroline Hepker on the sidelines of the governing Labour Party's annual conference in Liverpool. "The way we have to build data centers in this country has to be with a sense of control and a sense of British values," he adds.

Kura Oncology (NASDAQ:KURA) and Caspian Therapeutics presented preclinical findings for KO-7246, an investigational diabetes treatment candidate, at the European Association for the Study of Diabetes (EASD) meeting in Milan.

FreeCast (NASDAQ:CAST) filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, highlighting progress in its transition from technology development toward commercial deployment of its Platform-as-a-Service (PaaS) strategy.

Tesla’s (NASDAQ:TSLA) Full Self-Driving (FSD) system is facing regulatory scrutiny in Europe after the European Transport Safety Council (ETSC) urged European Union member states to reject approval of the driver-assistance technology.

Jaguar Health (NASDAQ:JAGX) announced that an abstract covering preliminary results from an adult short bowel syndrome study has been accepted for presentation at the American College of Gastroenterology (ACG) 2026 meeting.

Pearson (NYSE:PSO) agreed to acquire Workera, a company that provides AI-powered workforce skills assessment solutions for enterprises.

HUTCHMED (NASDAQ:HCM) announced that AstraZeneca (NASDAQ:AZN) submitted a U.S. regulatory application for ORPATHYS in combination with TAGRISSO for patients with MET-driven EGFR-mutated non-small cell lung cancer.

Julius Baer has applied for permission to restart share buybacks after Swiss regulator Finma concluded its enforcement procedure against the wealth manager, removing a long-standing overhang that has weighed on the stock. Juilius Baer came under scrutiny following steep losses from dealings with Austrian property tycoon Rene Benko. Bloomberg's Tom Metcalf explains.

Quantum-Si (NASDAQ:QSI) reported interim results showing that its developmental Proteus protein-sequencing platform outperformed its Platinum Pro system across multiple performance measures.

Hormel Foods (NYSE:HRL) declared a quarterly common-stock dividend of $0.2925 per share, continuing the company’s long history of returning capital to shareholders.

Evotec (NASDAQ:EVO) announced that Chief Scientific Officer Cord Dohrmann will step down from his role on September 30, 2026, by mutual consent.

Novo Nordisk (NYSE:NVO) agreed to license Hengrui Pharma’s phase 1-ready oral candidate HRS-1596 in a transaction valued at up to $2.6 billion.